We have shown that G-CSF treatment generatessplenic neutrophils that inhibit GVHD, but if neutrophils were obtained from IL-10knockout mice, this protection was largely abolished, showing the importance ofdonor-generated neutrophil-derived IL-10 to inhibit GVHD. Here, IL10 is linked to graft versus host disease.